expert roundtables

Interpreting Chronic Lymphocytic Leukemia Prognostic Markers in the Novel Treatment Era

by Jennifer R. Brown, MD, PhD, Jan A. Burger, MD, PhD, Anthony Mato, MD, MSCE

Prognostic markers for chronic lymphocytic leukemia (CLL) were developed in the previous treatment era and have the potential to take on new or per......READ MORE

LATEST IN EXPERT PERSPECTIVES

Browse More Articles